11 Einträge gefunden

1. Donor genetic determinant of thymopoiesis rs2204985 impacts clinical outcome after single HLA mismatched hematopoietic stem cell transplantation

   1. Tsamadou, Chrysanthi
   2. Gowdavally, Sowmya
   3. Platzbecker, Uwe
   4. Sala, Elisa
   5. Valerius, Thomas
   6. Wagner-Drouet, Eva
   7. Wulf, Gerald

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Higher risk for chronic graft-versus-host disease (GvHD) in HLA-G mismatched transplants following allogeneic hematopoietic stem cell transplantation: A retrospective study

   1. Neuchel, Christine
   2. Gowdavally, Sowmya
   3. Tsamadou, Chrysanthi
   4. Platzbecker, Uwe
   5. Sala, Elisa
   6. Wagner-Drouet, Eva
   7. Valerius, Thomas

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Rituximab Maintenance Versus Observation After Immunochemotherapy (R-CHOP, R-MCP, and R-FCM) in Untreated Follicular Lymphoma Patients: A Randomized Trial of the Ostdeutsche Studiengruppe Hämatologie und Onkologie and the German Low-Grade Lymphoma Study Group

   1. Hirt, Carsten
   2. Hoster, Eva
   3. Unterhalt, Michael
   4. Hänel, Mathias
   5. Prange-Krex, Gabriele
   6. Forstpointner, Roswitha
   7. Florschütz, Axel

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. HLA-DRB3/4/5 Matching Improves Outcome of Unrelated Hematopoietic Stem Cell Transplantation

   1. Tsamadou, Chrysanthi
   2. Engelhardt, Daphne
   3. Platzbecker, Uwe
   4. Sala, Elisa
   5. Valerius, Thomas
   6. Wagner-Drouet, Eva
   7. Wulf, Gerald

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
5. Comparison Between 5-Azacytidine Treatment and Allogeneic Stem-Cell Transplantation in Elderly Patients With Advanced MDS According to Donor Availability (VidazaAllo Study)

   1. Kröger, Nicolaus
   2. Sockel, Katja
   3. Wolschke, Christine
   4. Bethge, Wolfgang
   5. Schlenk, Richard F
   6. Wolf, Dominik
   7. Stadler, Michael

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
6. Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia

   1. Michallet, Mauricette
   2. Dreger, Peter
   3. Sobh, Mohamad
   4. Koster, Linda
   5. Hoek, Jennifer
   6. Boumendil, Ariane
   7. Scheid, Christof

   2020 - Forschungsinformationssystem des UKE
7. The Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness: A German Multicenter Analysis

   1. Mytilineos, Daphne
   2. Tsamadou, Chrysanthi
   3. Neuchel, Christine
   4. Platzbecker, Uwe
   5. Bunjes, Donald
   6. Schub, Natalie
   7. Wagner-Drouet, Eva

   2020 - Forschungsinformationssystem des UKE - frei zugänglich
8. Midostaurin added to chemotherapy and continued single agent maintenance therapy in acute myeloid leukemia with FLT3-ITD

   1. Schlenk, Richard F
   2. Weber, Daniela
   3. Fiedler, Walter
   4. Salih, Helmut R
   5. Wulf, Gerald
   6. Salwender, Hans
   7. Schroeder, Thomas

   2019 - Forschungsinformationssystem des UKE
9. Chemotherapy-Based Stem Cell Mobilization Does Not Result in Significant Paraprotein Reduction in Myeloma Patients in the Era of Novel Induction Regimens

   1. Oyekunle, Anthony
   2. Shumilov, Evgenii
   3. Kostrewa, Philippe
   4. Burchert, Andreas
   5. Trümper, Lorenz
   6. Wuchter, Patrick
   7. Wulf, Gerald

   2018 - Forschungsinformationssystem des UKE
10. Impact of ruxolitinib pretreatment on outcomes after allogeneic stem cell transplantation in patients with myelofibrosis

    1. Shahnaz Syed Abd Kadir, Sharifah
    2. Christopeit, Maximilian
    3. Wulf, Gerald
    4. Wagner, Eva
    5. Bornhauser, Martin
    6. Schroeder, Thomas
    7. Crysandt, Martina

    2018 - Forschungsinformationssystem des UKE
11. Osteolytic lesions occur rarely in patients with B-CLL and may respond well to ibrutinib

    1. Shumilov, Evgenii
    2. Wulf, Gerald
    3. Ströbel, Philipp
    4. Hasenkamp, Justin
    5. Hellige, Niels
    6. Bleckmann, Annalen
    7. Haase, Detlef

    2016 - Forschungsinformationssystem des UKE